Cargando…
Rapid clinical improvement of peripheral artery occlusive disease symptoms after nilotinib discontinuation despite persisting vascular occlusion
Autores principales: | Maurizot, A, Beressi, J-P, Manéglier, B, de la Marre, N H, Spentchian, M, Soury, P, Solvet-Sebire, P, Collet-Gaudillat, C, Baud, J-M, Livarek, B, Guilhot, F, Rousselot, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183775/ https://www.ncbi.nlm.nih.gov/pubmed/25238138 http://dx.doi.org/10.1038/bcj.2014.66 |
Ejemplares similares
-
Concentration of low-density lipoproteins (LDL) is significantly reduced after nilotinib discontinuation
por: Roa-Chamorro, Ricardo, et al.
Publicado: (2023) -
Safe discontinuation of nilotinib in a patient with chronic myeloid leukemia: a case report
por: Caocci, Giovanni, et al.
Publicado: (2014) -
Acute superior mesenteric artery occlusion complicated by basilar artery occlusion
por: Chatra, P.S.
Publicado: (2017) -
Treatment-free remission after discontinuation of imatinib, dasatinib, and nilotinib in patients with chronic myeloid leukemia
por: Han, Jae Joon
Publicado: (2023) -
Object Segmentation from Motion Discontinuities and Temporal
Occlusions–A Biologically Inspired Model
por: Beck, Cornelia, et al.
Publicado: (2008)